Literature DB >> 15001150

Health and hospitalistions after discharge in extremely low birth weight infants.

Lex W Doyle1, Geoffrey Ford, Noni Davis.   

Abstract

Apart from higher rates of mortality and adverse neurosensory outcome, extremely low birth weight (ELBW, birth weight 500-999 g) children have more hospital readmissions and other health problems in the early years after discharge than do normal birth weight (NBW, birth weight >2499 g) children. Respiratory illnesses, including lower respiratory infections, are the dominant cause for hospital readmission. ELBW survivors with bronchopulmonary dysplasia (BPD) have even more ill-health and hospital readmissions than do ELBW survivors without BPD. ELBW survivors require closer surveillance after discharge, not only for adverse neurosensory outcome, but also for other general health problems in early childhood.

Entities:  

Mesh:

Year:  2003        PMID: 15001150     DOI: 10.1016/S1084-2756(02)00221-X

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  21 in total

1.  Polysomnography in preterm infants and children with chronic lung disease.

Authors:  Sharon A McGrath-Morrow; Timothy Ryan; Brian M McGinley; Sande O Okelo; Laura M Sterni; J Michael Collaco
Journal:  Pediatr Pulmonol       Date:  2011-08-03

2.  Tobacco smoke in infants with bronchopulmonary dysplasia.

Authors:  Stéphanie Martinez; Patricia Garcia-Meric; Véronique Millet; Mellie Aymeric-Ponsonnet; Khuder Alagha; Jean-Christophe Dubus
Journal:  Eur J Pediatr       Date:  2015-01-30       Impact factor: 3.183

3.  Randomized Controlled Trial of Bovine Lactoferrin for Prevention of Sepsis and Neurodevelopment Impairment in Infants Weighing Less Than 2000 Grams.

Authors:  Theresa J Ochoa; Jaime Zegarra; Sicilia Bellomo; Cesar P Carcamo; Luis Cam; Anne Castañeda; Aasith Villavicencio; Jorge Gonzales; Maria S Rueda; Christie G Turin; Alonso Zea-Vera; Daniel Guillen; Miguel Campos; Linda Ewing-Cobbs
Journal:  J Pediatr       Date:  2020-02-06       Impact factor: 4.406

4.  Effect of Family-centered Care on Improving Parental Satisfaction and Reducing Readmission among Premature Infants: A Randomized Controlled Trial.

Authors:  Farideh Bastani; Tayebe Ali Abadi; Hamid Haghani
Journal:  J Clin Diagn Res       Date:  2015-01-01

5.  Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus.

Authors:  Michael A O'Reilly; Shauna H Marr; Min Yee; Sharon A McGrath-Morrow; B Paige Lawrence
Journal:  Am J Respir Crit Care Med       Date:  2008-02-21       Impact factor: 21.405

Review 6.  Infection-induced inflammation and cerebral injury in preterm infants.

Authors:  Tobias Strunk; Terrie Inder; Xiaoyang Wang; David Burgner; Carina Mallard; Ofer Levy
Journal:  Lancet Infect Dis       Date:  2014-05-28       Impact factor: 25.071

7.  Gender differences in respiratory symptoms in 19-year-old adults born preterm.

Authors:  Elianne J L E Vrijlandt; Jorrit Gerritsen; H Marike Boezen; Eric J Duiverman
Journal:  Respir Res       Date:  2005-10-13

8.  Long term follow up of high risk children: who, why and how?

Authors:  Lex W Doyle; Peter J Anderson; Malcolm Battin; Jennifer R Bowen; Nisha Brown; Catherine Callanan; Catherine Campbell; Samantha Chandler; Jeanie Cheong; Brian Darlow; Peter G Davis; Tony DePaoli; Noel French; Andy McPhee; Shusannah Morris; Michael O'Callaghan; Ingrid Rieger; Gehan Roberts; Alicia J Spittle; Dieter Wolke; Lianne J Woodward
Journal:  BMC Pediatr       Date:  2014-11-17       Impact factor: 2.125

9.  Low-dose hyperoxia primes airways for fibrosis in mice after influenza A infection.

Authors:  Andrew M Dylag; Jeannie Haak; Rachel Warren; Min Yee; Gloria S Pryhuber; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-07-29       Impact factor: 6.011

Review 10.  Born too soon: the global epidemiology of 15 million preterm births.

Authors:  Hannah Blencowe; Simon Cousens; Doris Chou; Mikkel Oestergaard; Lale Say; Ann-Beth Moller; Mary Kinney; Joy Lawn
Journal:  Reprod Health       Date:  2013-11-15       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.